IOBT Stocktwits, News and Mentions. Forecasting IO Biotech, Inc. Sentiments
All stock predictions
All currency forecasts
All cryptocurrency predictions

This Month Predictions for IOBT stock
IO Biotech, Inc. Analysis
IOBT Stock News


Popular stocks:
Suncor Energy
Amazon
Energy Transfer
Square
Etsy
Micron
Tilray

TOP Stocks:
Microsoft
Apple
Tesla
Alibaba
Amazon
American Airlines
NVIDIA
Adobe

Shares of other companies:
Consolidated Edison
Plains GP Holdings
Pinduoduo
XL Fleet
Intuit
LyondellBasell
Dogness (International)
McKesson
NexGen Energy
Moody's


Financial News

Popular Stocks Analysis

Helpful Highlights
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
  1. Home
    2. »
  2. Company News and Mentions
    3. »
  3. IOBT

IOBT Stock News and Mentions of IO Biotech, Inc. Stocktwits

Updated: April 20, 2024 (09:15)

Sector: Healthcare

Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.

We meticulously analyze the sentiment trend in each article for the last 60 days where IO Biotech Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of IO Biotech, Inc. (IOBT).

You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the IO Biotech stocks.

Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles

News and Mentions of IO Biotech, Inc. (IOBT)

April 9, 2024 (16:00) / "GlobeNewswire" (by IO Biotech)

IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, ...
In Article Trend: Neutral
April 5, 2024 (12:30) / "GlobeNewswire" (by IO Biotech)

IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
NEW YORK, April 05, 2024 ( GLOBE NEWSWIRE ) -- IO Biotech ( Nasdaq: IOBT ) , a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win® platform, today announced that Faiçal Miyara, Ph.D., has been appointed as the company's ...
In Article Trend: Neutral
March 6, 2024 (21:11) / "Benzinga" (by Globe Newswire)

IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research ( AACR ) Annual Meeting - IO Biotech ( NASDAQ:IOBT )

New nonclinical data strengthen evidence of individual contribution of IO102 and IO103 in controlling tumor growth
In Article Trend: Neutral
March 6, 2024 (21:11) / "GlobeNewswire" (by IO Biotech)

IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research ( AACR ) Annual Meeting
IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting ...
In Article Trend: Neutral
March 5, 2024 (21:40) / "GlobeNewswire" (by IO Biotech)

IO Biotech Announces 2023 Fourth-Quarter and Year-End Results
• Completed enrollment of pivotal Phase 3 trial of lead investigational therapeutic cancer vaccine, IO102-IO103, in combination with KEYTRUDA® ( pembrolizumab ) , in patients with advanced melanoma.
In Article Trend: Neutral



Related stocks from Healthcare sector

Codex DNA, Inc. (DNAY)
Cigna Corp. (CI)
Teladoc Health, Inc. (TDOC)
Virios Therapeutics, Inc. (VIRI)
Bristol-Myers Squibb Company (BMY)
Kodiak Sciences Inc. (KOD)
Ocuphire Pharma, Inc. (OCUP)
Galera Therapeutics, Inc. (GRTX)
Canopy Growth Corp. (CGC)
Enveric Biosciences, Inc. (ENVB)


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.


This website uses cookies to ensure you get the best experience on our website